MOONLAKE IMMUNOTHERAPEUTICS's ticker is and the CUSIP is 61559X104. A total of 133 filers reported holding MOONLAKE IMMUNOTHERAPEUTICS in Q4 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $956,403,957 | -12.5% | 21,751,284 | 0.0% | 26.80% | -10.8% |
Q1 2024 | $1,092,566,995 | -16.8% | 21,751,284 | 0.0% | 30.04% | -8.6% |
Q4 2023 | $1,313,560,041 | +5.9% | 21,751,284 | 0.0% | 32.87% | -1.7% |
Q3 2023 | $1,239,823,188 | +11.8% | 21,751,284 | 0.0% | 33.43% | +8.1% |
Q2 2023 | $1,109,315,484 | +138.4% | 21,751,284 | 0.0% | 30.92% | +81.8% |
Q1 2023 | $465,259,965 | +103.7% | 21,751,284 | 0.0% | 17.01% | +76.4% |
Q4 2022 | $228,388,482 | +31.9% | 21,751,284 | 0.0% | 9.64% | +34.8% |
Q3 2022 | $173,140,000 | +51.6% | 21,751,284 | 0.0% | 7.15% | +29.7% |
Q2 2022 | $114,194,000 | – | 21,751,284 | – | 5.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 21,751,284 | $465,259,965 | 17.01% |
Cormorant Asset Management, LP | 6,892,101 | $147,422 | 9.71% |
HighVista Strategies LLC | 122,201 | $2,613,879 | 2.13% |
Ally Bridge Group (NY) LLC | 72,850 | $1,558,262 | 2.04% |
Ghost Tree Capital, LLC | 195,000 | $4,171,000 | 1.23% |
GREAT POINT PARTNERS LLC | 278,334 | $5,953,564 | 1.17% |
SILVERARC CAPITAL MANAGEMENT, LLC | 105,750 | $2,261,993 | 0.93% |
SVB FINANCIAL GROUP | 16,173 | $345,940 | 0.66% |
Velan Capital Investment Management LP | 23,400 | $500,526 | 0.43% |
BOULDER HILL CAPITAL MANAGEMENT LP | 14,500 | $310,155 | 0.25% |